Se utiliza para mejorar el rendimiento fsico , favorecer la prdida de grasa , acelerar la recuperacin muscular y apoyar la salud cardiovascular y cognitiva
Clinical trial data provides objective evidence about efficacy (24.2% weight loss at 48 weeks), safety (88.8% completion rate), side effects (peak at weeks 6-8, resolve by week 12 for most), and discontinuation outcomes (70-80% regain over 12-18 months, not immediately)
Losing weight can be a difficult journey, and many people explore different options to find the be
Will the prescriber tell my GP
Neuroimage 24, 862873.CrossRefGoogle ScholarPubMed de Luis, DA, Aller, R, Izaola, O and Bachiller, R (2015) Role of rs6923761 gene variant in glucagon-like peptide 1 receptor in basal GLP-1 levels, cardiovascular risk factor and serum adipokine levels in naive type 2 diabetic patients
Even patients who dont lose weight on GLP-1s will often still see improvements in blood sugar if they have diabetes